The Division of Intramural Research (DIR) conducts basic and clinical research in a wide range of disciplines related to immunology, allergy, and infectious diseases. Our purpose is to make scientific discoveries that promote the development of new vaccines, therapeutics, and diagnostics to improve human health.
Media Availability: High Hepatitis C Cure Rate Seen in NIH-Led Trial of Six-Week Oral Drug Regimens—Jan. 12, 2015
New Mouse Study Method Enables Comparative Vaccine Studies for Tularemia—Dec. 29, 2014
New Variation of Genetic Immune Disorder Identified—Dec. 8, 2014
Scientists Pinpoint Factors Contributing to Resistance to Key Malaria Drug—Dec. 11, 2014
All DIR News Releases
Last Updated January 12, 2015